Big Changes in Today’s Global Wound Care Market

18 December 2019
Pharma

As one of today’s fastest-growing industries, the global wound care market certainly shows no signs of slowing down any time soon. Those armed with the right industry knowledge can make decisions to solidify their long-term success in the marketplace, which is why Visiongain is excited to share some of the big changes the industry is undergoing.

Here you’ll find out some of the things that can provide big opportunities for business owners and manufacturers in the wound care market.

Exciting Body Regenerative Solutions for Wound Care

One new and exciting change for the wound care market involves regenerative skincare solutions. Recently, biotech company BioLab Sciences has received numerous awards for its MyOwn Skin product, which provides a healing alternative to burn victims suffering from chronic, non-healing wounds. By using this innovative wound care technology, skin grafts are created from a small sample of the patient’s skin that minimizes the need for invasive removal of areas of healthy skin elsewhere on the patient’s body.

New Wound Care Applications for Fish Skin

Another exciting and groundbreaking wound care discovery comes from the company specializing in medical fish skin; Kerecis, who have pioneered new technology involving the use of fish skin in regenerative wound care. The new technology was introduced at this year’s Symposium on Advanced Wound Care held in October. The product, known as Kerecis Omega3 Wound, provides medical practitioners with fish skin that, when grafted on to human tissue, converts itself into living human tissue with the help of the human cells it recruits.

3M Acquires Wound Care firm Acelity

In the largest acquisition in 3M’s history, the company recently purchased wound care firm Acelity for a whopping $6.7 billion. This means manufacturers 3M are going to be expanding into the wound care dressing and therapy market and increasing their offerings in those sectors, which will likely affect market size in the coming years. One of their spokesmen said the recent purchase is in-line with their commitment of delivering comprehensive health care solutions for patients.

Let Visiongain help you get the most returns!

Above are just a few of the exciting new changes affecting the wound care market. If you want to be armed with the necessary insight to make the right decisions in the years ahead, Visiongain would love to hear from you. With more than 1,500 in-depth market reports spanning more than 18 market verticals, we can give you the tools you need to create long-term success in the wound care market. Contact us online today or call +44 (0) 20 7549 9987.

Recent News

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Visiongain Publishes Clinical Perinatal Software Market Report 2020-2030

Various research studies are currently underway, which are expected to create a competitive advantage for manufacturers to develop new and innovative and advanced software that is expected to provide a variety of additional opportunities in the perinatal clinical software market.

01 July 2020

Read

Visiongain publishes Clinical Laboratory Tests Market Report 2020-2030

Growing investment in target diagnosis of cardiovascular disorders, TB and diabetes drives demand for clinical laboratory testing. Clinical lab tests help in diagnosing mellitus diabetes. According to the International Diabetes Federation article published in 2019, some 463 million adults were diabetic, and it is estimated that it will reach 700 million worldwide by 2045.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever